First FDA-Approved Study of Stem Cells to Treat Hearing Loss Begins at Children's Memorial Hermann Hospital

HOUSTON , Jan. 12, 2012 /PRNewswire/ -- Children's Memorial Hermann Hospital and Cord Blood Registry® (CBR) are launching the first FDA-approved, Phase I safety study on the use of cord blood stem cells ...

Roche's Sequence Capture Technology Used to Identify SMPX Mutations Underlying Human Hereditary Hearing Loss

MADISON, Wisconsin , January 12, 2012 /PRNewswire/ --Hereditary hearing loss is the most common sensory disorder in humans. A German research team led by Ingo Kurth from the Institute of Human Genetics ...

NimbleGen Sequence Capture 385K array identifies gene mutations linked with hereditary hearing loss

Hereditary hearing loss is the most common sensory disorder in humans. A German research team led by Ingo Kurth from the Institute of Human Genetics at the University Hospital Jena, Germany, used a number of different methods, including Roche's NimbleGen Custom Sequence Capture 385K array to identify the gene mutated in the disease locus of the X-chromosome of a Spanish family with hereditary ...

Amy Winehouse’s Death Inquiry Second Guessed as Coroner Resigns

Although it seemed that the final chapter of the often sad life and very premature death of singer Amy Winehouse closed with her autopsy, cremation and funeral, it appears that the wound of the loss of their daughter will be reopened for the Winehouse family as some very troubling questions have emerged about the qualifications [...] Amy Winehouse’s Death Inquiry Second Guessed as Coroner ...

Nitric Oxide - Therapeutics, Markets and Companies

NEW YORK, Feb. 2, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Nitric Oxide - Therapeutics, Markets and Companies http://www.reportlinker.com/p0203547/Nitric-Oxide---Therapeutics-Markets-and-Companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=PathologyThis ...